InvestorsHub Logo
Followers 0
Posts 659
Boards Moderated 0
Alias Born 02/01/2018

Re: None

Sunday, 07/08/2018 7:59:03 AM

Sunday, July 08, 2018 7:59:03 AM

Post# of 32016
"Today's Mannkind humor comes courtesy Dr. Kendall, CMO:

https://www.endocrineweb.com/news/diabetes/59836-inhaled-insulin-afrezza-ready-prime-time

"Inhaled Insulin: Is Afrezza Ready for Prime Time?"

You don't say:

“We believe [technosphere inhaled insulin] creates the opportunity to revolutionize how mealtime postprandial glucose can be controlled, and we are continuing to do studies to better understand both the safety but more importantly the dosing and effectiveness of using Afrezza for mealtime therapy...”

Well, that's reassuring, isn't it? Dr. Kendall is openly ADMITTING that they STILL LACK sufficient studies to:

1) establish SAFETY

2) establish dosing

3) establish effectiveness

Well, gee, doc, considering the drug has been on the market three and a half YEARS now, one would be inclined to THINK that they would have figured all this stuff out BEFORE they launched it -- right? Any ESTIMATE about how many MORE YEARS before you FINALLY get the answers?"
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNKD News